sq 28603 has been researched along with natriuretic peptide, c-type in 1 studies
| Studies (sq 28603) | Trials (sq 28603) | Recent Studies (post-2010) (sq 28603) | Studies (natriuretic peptide, c-type) | Trials (natriuretic peptide, c-type) | Recent Studies (post-2010) (natriuretic peptide, c-type) |
|---|---|---|---|---|---|
| 35 | 0 | 0 | 1,413 | 31 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboa-Offei, BE; Asaad, MM; Mathers, PD; Seymour, AA; Weber, H | 1 |
1 other study(ies) available for sq 28603 and natriuretic peptide, c-type
| Article | Year |
|---|---|
Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cyclic GMP; Enzyme Inhibitors; Female; Kidney; Macaca fascicularis; Natriuretic Peptide, C-Type; Neprilysin; Proteins; Sodium | 1996 |